SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-20-043360
Filing Date
2020-12-18
Accepted
2020-12-18 06:16:38
Documents
1
Period of Report
2020-12-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 4218
  Complete submission text file 0001213900-20-043360.txt   5620
Mailing Address 9301 AMBERGLEN BOULEVARD, SUITE 100 C/O MOLECULAR TEMPLATES, INC. AUSTIN TX 78729
Business Address
Cutler Adam D. (Reporting) CIK: 0001722673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39685 | Film No.: 201397949

Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Issuer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations